In a statement, it wrote that «any allegations of disregard for consumers who need these lifesaving drugs, government officials, regulators or any other of our valued stakeholders are patently false and wholly inconsistent with the company's culture, mission and track record of
delivering access to medicine.»
Not exact matches
To deliver a thriving animal medicines sector, post-Brexit, NOAH has set out a series of priorities that will: - Support trade and innovation - Safeguard animal health and welfare and public health and food safety; ensuring that UK veterinarians and animal keepers continue to have access to a wide range of appropriate veterinary medicine
To deliver a thriving animal
medicines sector, post-Brexit, NOAH has set out a series of priorities that will: - Support trade and innovation - Safeguard animal health and welfare and public health and food safety; ensuring that UK veterinarians and animal keepers continue
to have access to a wide range of appropriate veterinary medicine
to have
access to a wide range of appropriate veterinary medicine
to a wide range of appropriate veterinary
medicines.
To deliver a thriving animal medicines sector, post-Brexit, NOAH has set out a series of priorities that will: Support trade and innovation Safeguard animal health and welfare and public health and food safety; ensuring that UK veterinarians and animal keepers continue to have access to a wide range of appropriate veterinary medicine
To deliver a thriving animal
medicines sector, post-Brexit, NOAH has set out a series of priorities that will: Support trade and innovation Safeguard animal health and welfare and public health and food safety; ensuring that UK veterinarians and animal keepers continue
to have access to a wide range of appropriate veterinary medicine
to have
access to a wide range of appropriate veterinary medicine
to a wide range of appropriate veterinary
medicines.
Now, a multidisciplinary research team led by David Eckmann, MD, PhD, Horatio C. Wood Professor of Anesthesiology and Critical Care at the Perelman School of
Medicine at the University of Pennsylvania and professor of Bioengineering in Penn's School of Engineering and Applied Science, has found that when
delivered by a microscopic transporter called a nanocarrier, steroids can
access the hard -
to - reach lung endothelial cells that need it most and are successful at preventing inflammation in mice.
With a reputation for world - renowned expertise in regenerative
medicine, this not - for - profit enterprise was built around an academic consortium that
delivers a robust pipeline of discoveries and
access to intellectual property (IP).
That mission has led
to the integration of SRS into veterinary
medicine, providing pet owners across the country with
access to advanced radiation therapy
delivered with sub-millimeter precision unprecedented in veterinary
medicine.
Vertisis offers doctors
access to custom compounded, personalized
medicine for their patients,
delivered directly
to their practice or facility.